The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; Bouchara Recordati; Ipsen; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen; Pfizer; Pierre Fabre

Clinical predictors of sarcomatoid kidney cancer: The results of a UCLA and french UroCCR network collaboration.
 
Cedric Michel Lebacle
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Aydin Pooli
Stock and Other Ownership Interests - Allogene Therapeutics; UroGen pharma
 
Jean-Christophe Bernhard
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer
Research Funding - Baxter (Inst); Intuitive Surgical (Inst); Roche (Inst)
 
Philippe Paparel
No Relationships to Disclose
 
Karim Bensalah
No Relationships to Disclose
 
Jean Baptiste Beauval
No Relationships to Disclose
 
Arnaud Mejean
Honoraria - Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Novartis; Roche
 
Charles Dariane
Travel, Accommodations, Expenses - Astellas Pharma
 
Pierre Bigot
No Relationships to Disclose
 
Herve Lang
No Relationships to Disclose
 
Thomas Bessede
No Relationships to Disclose
 
Alexandre De La Taille
No Relationships to Disclose
 
Morgan Roupret
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Lilly; Roche; Sanofi
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Janssen; Lilly; Roche; Sanofi
 
Jacques Irani
Honoraria - Astellas Pharma; Ipsen
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Janssen
 
Jean-Jacques Patard
No Relationships to Disclose
 
Arie S. Belldegrun
Employment - Alimera Sciences; Kronos; UroGen pharma
Leadership - Alimera Sciences; Kronos; UroGen pharma
Stock and Other Ownership Interests - Alimera Sciences; Kronos; UroGen pharma
 
Brian Shuch
No Relationships to Disclose
 
Karim Chamie
Consulting or Advisory Role - AstraZeneca; Urogen pharma
Other Relationship - Altor BioScience
 
Alexandra Drakaki
Employment - Kyn therapeutics (I)
Leadership - Kyn therapeutics (I)
Stock and Other Ownership Interests - Alimera Sciences (I); UROGENE (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Kyn therapeutics
Research Funding - Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - 5 PATENTS AT UCLA FOR 5 POTENTIAL DRUGS (I)
Travel, Accommodations, Expenses - Lilly
 
Allan J. Pantuck
Employment - Kyn Therapeutics
Leadership - Kyn Therapeutics
Stock and Other Ownership Interests - Alimera Sciences; Urogene
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer